Role of inflammation in the etiopathogenesis of COPD;Papel de la inflamación en la etiopatogenia de la EPOC

Archivos de Bronconeumologia

Volumn 46, Issue SUPPL.11, 2010, Pages 2-7

  del Puerto Nevado, Laura ^a   Pérez Rial, Sandra ^a   Girón Martínez, Álvaro ^a   Peces Barba, Germán ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

COPD; Immunity; Inflammatory mediators

Indexed keywords

TOBACCO SMOKE;

ADAPTIVE IMMUNITY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; FUNCTIONAL MORPHOLOGY; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; INNATE IMMUNITY; LUNG ALVEOLUS WALL; LUNG ARTERY PRESSURE; LYMPHOCYTE ACTIVATION; PNEUMONIA; TISSUE REPAIR;

AIRWAY REMODELING; APOPTOSIS; CHEMOKINES; CYTOKINES; FIBRINOGEN; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INFLAMMATION MEDIATORS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOCYTE SUBSETS; MACROPHAGES; MODELS, BIOLOGICAL; NEUTROPHILS; OXIDATIVE STRESS; PEPTIDE HYDROLASES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKE; TOBACCO;

EID: 79851496483     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/S0300-2896(10)70055-7     Document Type: Article

References (55)

1. Rahman I.M.W. Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease. Thorax 1996, 51:348-350.
2. MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005, 2:50-60.
3. Enami S.H.M., Colussi A.J. Acidity enhances the formation of a persistent ozonide at aqueous ascorbate/ozone gas interfaces. Proc Natl Acad Sci USA 2008, 105:7365-7369.
4. Li X.Y., Donaldson K., MacNee W. Mechanisms of cigarette smoke induced increased airspace permeability. Thorax 1996, 51:465-471.
5. Jones J.G., Lawler P., Hulands G., Crawley J.C., Veall N. Increased alveolar epithelial permeability in cigarette smokers. Lancet 1980, 1:66-68.
6. Rao T., Richardson B. Environmentally induced autoimmune diseases: potential mechanisms. Environ Health Perspect 1999, 107(Suppl5):737-742.
7. Krieg A.M., Vollmer J. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev 2007, 220:251-269.
8. Parker L.C., Prince L.R., Sabroe I. Translational mini-review series on Toll-like receptors: networks regulated by Toll-like receptors mediate innate and adaptive immunity. Clin Exp Immunol 2007, 147:199-207.
9. Crespo-Lessmann A., Juárez-Rubio C., Plaza-Moral V. Role of toll-like receptors in respiratory diseases. Arch Bronconeumol 2010, 46:135-142.
10. Matzinger P. The danger model: a renewed sense of self. Science 2002, 296:301-305.
11. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 2006, 6:823-835.
12. Van Lint P., Libert C. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J Leukoc Biol 2007, 82:1375-1381.
13. Lee S.H., Goswami S., Grudo A., Song L.Z., Bandi V., Goodnight-White S., et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 2007, 13:567-569.
14. McWilliam AS, Napoli S, Marsh AM, Pemper FL, Nelson DJ, Pimm CL, et al. Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli. J Exp Med. 19961;184:2429-32.
15. Lambrecht B.N., Prins J.B., Hoogsteden H.C. Lung dendritic cells and host immunity to infection. Eur Respir J 2001, 18:692-704.
16. Górska K.M.-W.M., Krenke R. Airway inflammation in chronic obstructive pulmonary disease. Curr Opin Pulm Med 2010, 16:89-96.
17. Freeman C.M., Curtis J.L., Chensue S.W. CC chemokine receptor 5 and CXC chemokine receptor 6 expression by lung CD8+ cells correlates with chronic obstructive pulmonary disease severity. Am J Pathol 2007, 171:767-776.
18. Saetta M., Mariani M., Panina-Bordignon P., Turato G., Buonsanti C., Baraldo S., et al. Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002, 165:1404-1409.
19. Saetta M., Baraldo S., Corbino L., Turato G., Braccioni F., Rea F., et al. CD8+ ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 160:711-717.
20. Vernooy J.H., Moller G.M., Van Suylen R.J., Van Spijk M.P., Cloots R.H., Hoet P.H., et al. Increased granzyme A expression in type II pneumocytes of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007, 175:464-472.
21. Chrysofakis G., Tzanakis N., Kyriakoy D., Tsoumakidou M., Tsiligianni I., Klimathianaki M., et al. Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD. Chest 2004, 125:71-76.
22. Sullivan A.K., Simonian P.L., Falta M.T., Mitchell J.D., Cosgrove G.P., Brown K.K., et al. Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema. Am J Respir Crit Care Med 2005, 172:590-596.
23. Di Stefano A., Caramori G., Capelli A., Gnemmi I., Ricciardolo F.L., Oates T., et al. STAT4 activation in smokers and patients with chronic obstructive pulmonary disease. Eur Respir J 2004, 24:78-85.
24. Turato G., Zuin R., Miniati M., Baraldo S., Rea F., Beghe B., et al. Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema. Am J Respir Crit Care Med 2002, 166:105-110.
25. Van der Strate B.W., Postma D.S., Brandsma C.A., Melgert B.N., Luinge M.A., Geerlings M., et al. Cigarette smoke-induced emphysema: A role for the B cell?. Am J Respir Crit Care Med 2006, 173:751-758.
26. Shapiro S.D. End-stage chronic obstructive pulmonary disease: the cigarette is burned out but inflammation rages on. Am J Respir Crit Care Med 2001, 164:339-340.
27. Agustí A., MacNee W., Donaldson K., Cosio M. Hypothesis: does COPD have an autoimmune component?. Thorax 2003, 58:832-834.
28. Cosio M.G. Autoimmunity, T-cells and STAT-4 in the pathogenesis of chronic obstructive pulmonary disease. Eur Respir J 2004, 24:3-5.
29. Cosio M.G., Saetta M., Agustí A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009, 360:2445-2454.
30. Taraseviciene-Stewart L., Scerbavicius R., Choe K.H., Moore M., Sullivan A., Nicolls M.R., et al. An animal model of autoimmune emphysema. Am J Respir Crit Care Med 2005, 171:734-742.
31. Kuo Y.B., Chang C.A., Wu Y.K., Hsieh M.J., Tsai C.H., Chen K.T., et al. Identification and clinical association of anti-cytokeratin 18 autoantibody in COPD. Immunol Lett 2010, 128:131-136.
32. Feghali-Bostwick C.A., Gadgil A.S., Otterbein L.E., Pilewski J.M., Stoner M.W., Csizmadia E., et al. Autoantibodies in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008, 177:156-163.
33. Cosio M., Ghezzo H., Hogg J.C., Corbin R., Loveland M., Dosman J., et al. The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med 1978, 298:1277-1281.
34. Hogg J.C., Chu F., Utokaparch S., Woods R., Elliott W.M., Buzatu L., et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:2645-2653.
35. Saetta M., Di Stefano A., Turato G., Facchini F.M., Corbino L., Mapp C.E., et al. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 157(3 Pt 1):822-826.
36. Demedts I.K.D.T., Bracke K.R., Joos G.F., Brusselle G.G. Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res 2006, 7:53.
37. Kanazawa H.Y.J. Elevated oxidative stress and reciprocal reduction of vascular endothelial growth factor levels with severity of COPD. Chest 2005, 128:3191-3197.
38. Tuder R.M., Zhen L., Cho C.Y., Taraseviciene-Stewart L., Kasahara Y., Salvemini D., et al. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol 2003, 29:88-97.
39. Pauwels R.A., Buist A.S., Calverley P.M., Jenkins C.R., Hurd S.S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001, 163:1256-1276.
40. Agustí A.G., Noguera A., Sauleda J., Sala E., Pons J., Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003, 21:347-360.
41. Wouters E.F. Local and systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005, 2:26-33.
42. Noguera A., Busquets X., Sauleda J., Villaverde J.M., MacNee W., Agustí A.G. Expression of adhesion molecules and G proteins in circulating neutrophils in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 158(5 Pt 1):1664-1668.
43. Noguera A., Batle S., Miralles C., Iglesias J., Busquets X., MacNee W., et al. Enhanced neutrophil response in chronic obstructive pulmonary disease. Thorax 2001, 56:432-437.
44. Burnett D., Chamba A., Hill S.L., Stockley R.A. Neutrophils from subjects with chronic obstructive lung disease show enhanced chemotaxis and extracellular proteolysis. Lancet 1987, 2:1043-1046.
45. Cataldo D., Munaut C., Noel A., Frankenne F., Bartsch P., Foidart J.M., et al. Matrix metalloproteinases and TIMP-1 production by peripheral blood granulocytes from COPD patients and asthmatics. Allergy 2001, 56:145-151.
46. Hageman G.J., Larik I., Pennings H.J., Haenen G.R., Wouters E.F., Bast A. Systemic poly (ADP-ribose) polymerase-1 activation, chronic inflammation, and oxidative stress in COPD patients. Free Radic Biol Med 2003, 35:140-148.
47. Aldonyte R., Jansson L., Piitulainen E., Janciauskiene S. Circulating monocytes from healthy individuals and COPD patients. Respir Res 2003, 4:11.
48. Gan W.Q., Man S.F., Senthilselvan A., Sin D.D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004, 59:574-580.
49. Broekhuizen R., Wouters E.F., Creutzberg E.C., Schols A.M. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 2006, 61:17-22.
50. Agustí A.G., Sauleda J., Miralles C., Gómez C., Togores B., Sala E., et al. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002, 166:485-489.
51. Dahl M., Tybjaerg-Hansen A., Vestbo J., Lange P., Nordestgaard B.G. Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 164:1008-1011.
52. Di Francia M., Barbier D., Mege J.L., Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994, 150(5 Pt 1):1453-1455.
53. Dietrich M., Block G., Benowitz N.L., Morrow J.D., Hudes M., Jacob P., et al. Vitamin C supplementation decreases oxidative stress biomarker f2-isoprostanes in plasma of nonsmokers exposed to environmental tobacco smoke. Nutr Cancer 2003, 45:176-184.
54. Dietrich M., Block G., Hudes M., Morrow J.D., Norkus E.P., Traber M.G., et al. Antioxidant supplementation decreases lipid peroxidation biomarker F(2)-isoprostanes in plasma of smokers. Cancer Epidemiol Biomarkers Prev 2002, 11:7-13.
55. Vernooy J.H., Kucukaycan M., Jacobs J.A., Chavannes N.H., Buurman W.A., Dentener M.A., et al. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med 2002, 166:1218-1224.